Publication: Predictors of Liver Fibrosis in Patients with Chronic HCV Infection
No Thumbnail Available
Date
2012-12-01T00:00:00Z
Authors
Authors
Ceylan, Bahadir
Yardimci, Cem
Fincanci, Muzaffer
Tozalgan, Umit
Eren, Gulhan
Muderrisoglu, Cuneyt
Inci, Ayse
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Objective: The aim of this study was to investigate the independent variables for the degree of liver fibrosis in patients with chronic hepatitis C virus (HCV) infection. Material and Methods: In this cross-sectional retrospective study, the patients were divided in two groups as Group A (patients with fibrosis score 0-2) and Group B (patients with fibrosis score 3-4) and they were compared in terms of age, gender, body mass index, alcohol consumption, presence of diabetes, serum HCV RNA, alanine aminotransferase, gamma-glutamyl transferase, and aspartate aminotransferase, total bilirubin, albumin, globulin and alkaline phosphatase levels, prothrombin time, blood thrombocyte count, splenomegaly in ultrasonographic examination, HCV genotype and liver steatosis. Results: Of 201 patients, 93 (46.3%) were males; the median age was 51 (range: 18-77) years. It was found that serum gamma-glutamyl transferase and aspartate aminotransferase levels, age, prothrombin time and the presence of splenomegaly were independent variables predictive of advanced liver fibrosis. Odds ratio and p values were 1.984 and 0.013 for gamma-glutamyl transferase, 1.633 and 0.018 for aspartate aminotransferase, 1.861 and 0.003 for age, 5.598 and 0.008 for splenomegaly and 0.541 and 0.007 for prothrombin time, respectively. Conclusion: The results of this study suggested that advanced age, elevated serum gamma-glutamyl transferase and, aspartate aminotransferase levels, prolonged prothrombin time and the presence of splenomegaly are independent variables determining severe liver fibrosis.
Description
Keywords
Citation
Ceylan B., Yardimci C., Fincanci M., Tozalgan U., Eren G., Muderrisoglu C., Inci A., -Predictors of Liver Fibrosis in Patients with Chronic HCV Infection-, TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, cilt.32, ss.1522-1529, 2012